Rockefeller Capital Management »

Bioline Rx shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Bioline Rx (BLRX) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Bioline Rx

Tip: Access up to 7 years of quarterly data

All positions including Bioline Rx held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioline Rx by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $45 12 3.75

More positions owned by Rockefeller Capital Management

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
salesforce (CRM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Tidal Trust Iii Rockefeller Glob (RGEF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Tidal Trust Iii Rockefeller Us S (RSMC)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Rockefeller Capital Management

Top funds holding Bioline Rx

Susquehanna International
Citadel Advisors
UBS Group
Rhumbline Advisers
Wells Fargo & Company
Nemes Rush Group
Goss Wealth Management
Simplex Trading
Tower Research Capital
Rockefeller Capital Management
SBI Securities
Danske Bank A/s
Advisor Group Holdings

View all funds holding Bioline Rx